Skip to main content

Adults Screened for Inactivity Have Lower Rates of Comorbid Conditions

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 3, 2025.

By Elana Gotkine HealthDay Reporter

THURSDAY, Jan. 2, 2025 -- Adults screened for inactivity at well visits have lower rates of comorbid conditions, according to a study published online Jan. 2 in Preventing Chronic Disease.

Cole G. Chapman, Ph.D., from the University of Iowa in Iowa City, and colleagues examined the value of screening patients for physical activity in a study involving adults treated for a well visit between Nov. 1, 2017, and Dec. 1, 2022, at a large Midwestern university hospital. A total of 7,261 patients screened for inactivity were compared to 33,445 unscreened patients. Further comparisons were conducted between screened patients who were inactive, insufficiently active, or active (0, 1 to 149, and 150+ minutes/week of moderate-to-vigorous physical activity).

The researchers found that patients screened for inactivity presented with lower rates of several comorbid conditions, including obesity, diabetes, and hypertension, compared with unscreened patients. Significantly healthier cardiometabolic profiles and a lower risk for up to 19 inactivity-related comorbid conditions were seen for active versus insufficiently active and inactive patients.

"We believe this finding is a result of those patients who take the time to come in for annual wellness exams also are taking more time to engage in healthy behaviors, such as being physically active," coauthor Lucas J. Carr, Ph.D., from the University of Iowa Health Care Medical Center, said in a statement.

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

Read this next

In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity

TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...

GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression

MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...

Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery

THURSDAY, May 15, 2025 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.